VivoPower received Ripple’s approval to launch a $300 million institutional fund via a joint venture with Seoul-based Lean Ventures that will purchase Ripple Labs preferred shares to give institutions equity exposure instead of XRP tokens. VivoPower’s digital arm, Vivo Federation, will source and buy the shares. The fund targets South Korean demand, cites recent regulatory progress including an OCC banking license for Ripple, and is expected to generate about $75 million in management and performance fees over three years. VivoPower stock rose about 13% on the announcement.

Positive commercial development: a $300M fund approved by Ripple will buy Ripple Labs preferred shares (institutional equity exposure), targets South Korean demand, and cites regulatory tailwinds including an OCC banking license; VivoPower expects ~$75M in fees and its stock jumped ~13% after the announcement.